Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics

Author:

Wu Wan-Chen1ORCID,Peng Kang-Yung2,Lu Jin-Ying1,Chan Chieh-Kai3,Wang Chih-Yuan1,Tseng Fen-Yu1,Yang Wei-Shiung1,Lin Yen-Hung4ORCID,Lin Po-Chih4,Chen Ting-Chu5,Huang Kuo-How6,Chueh Jeff S67,Wu Vin-Cent8ORCID

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan

2. Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan

3. Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch , Hsinchu City, Taiwan

4. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan

5. Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch , Hsinchu City, Taiwan

6. Department of Urology, National Taiwan University Hospital , Taipei, Taiwan

7. Department of Urology, College of Medicine, National Taiwan University , Taipei, Taiwan

8. Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital , Taipei, Taiwan

Abstract

Abstract Objective Concurrent autonomous cortisol secretion (ACS) in patients with primary aldosteronism (PA) is being reported more frequently. Several somatic mutations including PRKACA, GNAS, and CTNNB1 were identified in cortisol-producing adenomas (CPAs). The presence of these mutations in unilateral PA (uPA) patients concurrent with ACS (uPA/ACS) is not well known. This study aimed to investigate the prevalence of these mutations and their clinical vs pathological characteristics in uPA/ACS. Design This is a retrospective cohort study. Methods Totally 98 uPA patients from the Taiwan Primary Aldosteronism Investigation registry having overnight 1-mg dexamethasone suppression test (DST) and adrenalectomy from 2016 to 2018 were enrolled. Their adrenal tumors were tested for PRKACA, GNAS, and CTNNB1 mutations. Results 11 patients had CPA-related mutations (7 PRKACA and 4 GNAS). The patients carrying these mutations had higher post-DST cortisol (5.6 vs 2.6 μg/dL, P = 0.003) and larger adenoma (2.2 ± 0.3 vs 1.9 ± 0.7 cm, P = 0.025). Adenomas with these mutations had a higher prevalence of non-classical uPA (72.7% vs 26.3%, P = 0.014). Numerically, slightly more complete clinical success of uPA patients with these mutations was noticed after adrenalectomy, although it was statistically non-significant. Post-DST cortisol levels, adenoma size >1.9 cm, and the interaction of adenoma size >1.9 cm with potassium level were found to be associated with the presence of these mutations. Conclusion Our study showed that CPA-related mutations were detected in 36.7% of uPA/ACS adenomas. The presence of these mutations was associated with higher post-DST cortisol levels, larger adenoma sizes, and a high percentage of non-classical uPA. However, these mutations did not significantly affect the clinical and biochemical outcomes after adrenalectomy of uPA/ACS patients but they showed a better trend.

Publisher

Oxford University Press (OUP)

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents;Mulatero;Journal of Clinical Endocrinology and Metabolism,2004

2. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients;Rossi;Journal of the American College of Cardiology,2006

3. Subclinical Cushing's syndrome;Reincke;Endocrinology and Metabolism Clinics of North America,2000

4. Subclinical Cushing's syndrome in adrenal incidentaloma;Terzolo;Clinical Endocrinology,1998

5. Management of adrenal incidentaloma;Terzolo;Best Practice and Research: Clinical Endocrinology and Metabolism,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3